France: Lauxera targets final close of €500m for second fund
Healthcare focused asset manager, Lauxera Capital Partners, has closed its Growth Fund II at €400m, and is eyeing…
UK: Terumo to acquire OrganOx for US$1.5bn in one of the largest-ever deals in the UK medtech sector
Tokyo-listed, Terumo, is a global medical device company originating from Japan, is acquiring OrganOx, a UK-based innovator in…